Tsz Hong Yiu

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 8

Top Topics

Patients With Inflammatory Bowel Disease

Ulcerative Colitis

Randomized Controlled Trial

Top Venues

Alimentary pharmacology & therapeutics

Internal medicine journal

This page only lists publications with an associated author ORCID identifier.

Publications

Tsz Hong Yiu, Yanna Ko, Aviv Pudipeddi, Patrizia Natale, Rupert W Leong
Letter: Persisting with persistence-A caution as an outcome measure in inflammatory bowel disease: Authors' reply. Alimentary pharmacology & therapeutics 60 (3) (2024)
Tsz Hong Yiu, Yanna Ko, Aviv Pudipeddi, Patrizia Natale, Rupert W Leong
Letter: Early real-world evidence from the United Arab Emirates of the persistence, effectiveness and safety of risankizumab for the treatment of Crohn's disease-Authors' reply. Alimentary pharmacology & therapeutics (2024)
Tsz Hong Yiu, Yanna Ko, Aviv Pudipeddi, Patrizia Natale, Rupert W Leong
Letter: Early real-world evidence from the United Arab Emirates of the persistence, effectiveness and safety of risankizumab for the treatment of Crohn's disease-Authors' reply. Alimentary pharmacology & therapeutics 60 (1) (2024)
Tsz Hong Yiu, Yanna Ko, Aviv Pudipeddi, Patrizia Natale, Rupert W Leong
Letter: Persisting with persistence-A caution as an outcome measure in inflammatory bowel disease: Authors' reply. Alimentary pharmacology & therapeutics (2024)
Tsz Hong Yiu, Elizabeth Chow, Claire Grills, Christopher F D Li Wai Suen
Concomitant management of alopecia universalis and ulcerative colitis with upadacitinib. Internal medicine journal 54 (9) (2024)
Tsz Hong Yiu, Yanna Ko, Aviv Pudipeddi, Patrizia Natale, Rupert W Leong
Letter: Early real-world evidence from the United Arab Emirates of the persistence, effectiveness and safety of risankizumab for the treatment of Crohn's disease-Authors' reply. Alimentary pharmacology & therapeutics 60 (1) (2024)
Tsz Hong Yiu, Yanna Ko, Aviv Pudipeddi, Patrizia Natale, Rupert W Leong
Letter: Persisting with persistence-A caution as an outcome measure in inflammatory bowel disease: Authors' reply. Alimentary pharmacology & therapeutics 60 (3) (2024)
Tsz Hong Yiu, Yanna Ko, Aviv Pudipeddi, Patrizia Natale, Rupert W Leong
Comparing persistence of new biologics to conventional anti-TNF alphas in adult patients with inflammatory bowel disease: a systematic review and meta-analysis protocol. BMJ open 13 (10) (2023)